Changchun BCHT Biotechnology Co. (SHA:688276)
China
· Delayed Price · Currency is CNY 23.25
+0.03 (0.13%)
Apr 2, 2025, 2:45 PM CST
SHA:688276 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Net Income | 414.29 | 501.01 | 181.54 | 243.55 | 418.23 | 221.02 | Upgrade
|
| Depreciation & Amortization | 91.99 | 91.99 | 70.94 | 68.34 | 58.86 | 42.76 | Upgrade
|
| Other Amortization | 7.01 | 7.01 | 5.68 | 0.99 | 0.66 | 0.11 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.9 | 0.9 | 0.73 | 2.19 | - | -15.34 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 0.05 | 12.17 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.69 | -0.69 | -0.31 | 1.02 | -6.42 | 13.9 | Upgrade
|
| Provision & Write-off of Bad Debts | 31.67 | 31.67 | 12.54 | 5.35 | -0.61 | - | Upgrade
|
| Other Operating Activities | 223.37 | 27.31 | 41.34 | 82.59 | 4.04 | 8.3 | Upgrade
|
| Change in Accounts Receivable | -691.36 | -691.36 | -171.36 | -40.04 | -418.58 | -48.14 | Upgrade
|
| Change in Inventory | -33.53 | -33.53 | 7.89 | -166.47 | -59.72 | 10.07 | Upgrade
|
| Change in Accounts Payable | 327.65 | 327.65 | -109.1 | -51.67 | 224.57 | -7.6 | Upgrade
|
| Operating Cash Flow | 364.55 | 255.21 | 39.82 | 140.3 | 209.16 | 232.8 | Upgrade
|
| Operating Cash Flow Growth | 43.56% | 540.93% | -71.62% | -32.92% | -10.15% | -13.71% | Upgrade
|
| Capital Expenditures | -540.27 | -470.66 | -290.73 | -632.88 | -335.75 | -128.39 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.04 | 0.04 | - | 0.02 | - | - | Upgrade
|
| Investment in Securities | - | -168 | - | -62.64 | - | - | Upgrade
|
| Other Investing Activities | 0.94 | - | 2.02 | - | 2.16 | - | Upgrade
|
| Investing Cash Flow | -539.3 | -638.63 | -288.72 | -695.51 | -333.59 | -128.39 | Upgrade
|
| Short-Term Debt Issued | - | 196.91 | - | 67.5 | 69.9 | 99.8 | Upgrade
|
| Total Debt Issued | 326.55 | 196.91 | - | 67.5 | 69.9 | 99.8 | Upgrade
|
| Short-Term Debt Repaid | - | -176.44 | - | -67.5 | -234.9 | -148.19 | Upgrade
|
| Total Debt Repaid | -263.97 | -176.44 | - | -67.5 | -234.9 | -148.19 | Upgrade
|
| Net Debt Issued (Repaid) | 62.58 | 20.47 | - | - | -165 | -48.39 | Upgrade
|
| Issuance of Common Stock | 19 | - | - | 1,413 | 350 | - | Upgrade
|
| Common Dividends Paid | -89.23 | -62.61 | -41.28 | - | - | - | Upgrade
|
| Other Financing Activities | - | - | - | -10.4 | -10.61 | -8.3 | Upgrade
|
| Financing Cash Flow | -7.65 | -42.14 | -41.28 | 1,402 | 174.39 | -56.69 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.18 | 0.5 | 1.66 | -0.1 | -0.1 | 0.1 | Upgrade
|
| Net Cash Flow | -182.21 | -425.06 | -288.52 | 847.05 | 49.86 | 47.81 | Upgrade
|
| Free Cash Flow | -175.73 | -215.46 | -250.91 | -492.58 | -126.58 | 104.4 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | 17.78% | Upgrade
|
| Free Cash Flow Margin | -10.93% | -11.81% | -23.42% | -40.98% | -8.78% | 10.70% | Upgrade
|
| Free Cash Flow Per Share | -0.42 | -0.52 | -0.61 | -1.25 | -0.34 | 0.29 | Upgrade
|
| Cash Interest Paid | 0.7 | 0.7 | - | 0.33 | 4.05 | 8.3 | Upgrade
|
| Cash Income Tax Paid | 177.03 | 121.49 | 77.93 | 102.54 | 121.75 | 68.87 | Upgrade
|
| Levered Free Cash Flow | -303.72 | -334.43 | -297.86 | -467.9 | -177.89 | 83.03 | Upgrade
|
| Unlevered Free Cash Flow | -302.81 | -333.99 | -297.86 | -467.69 | -175.35 | 88.22 | Upgrade
|
| Change in Net Working Capital | 175.09 | 333.3 | 189.03 | 53.78 | 194.24 | 2.41 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.